Christine Bellon
Vermögen: 3 Mio $ am 31.08.2026
Vermögen: 3 Mio $ am 31.08.2026
Christine Bellon is currently a Trustee at the Museum of Science and Chief Legal Officer at Beam Therapeutics, Inc. Formerly, Dr. Bellon was Patent Counsel at Wyeth LLC; Secretary, Vice President & General Counsel at Forma Therapeutics, Inc. from 2017 to 2019; Assistant General Counsel at Infinity Pharmaceuticals, Inc.; VP-Intellectual Property & Legal Affairs at Hydra Biosciences, Inc.; Attorney at Fish & Richardson PC; Secretary & Vice President-Legal Affairs at Blueprint Medicines Corp.; and Senior Vice President-Legal Affairs at Relay Therapeutics, Inc. from 2016 to 2017.
Education includes a doctorate from Massachusetts Institute of Technology, an undergraduate degree from Yale University, and a graduate degree from Columbia Law School.
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
BEAM THERAPEUTICS, INC. 0,11 % | 01.04.2026 | 109.711 ( 0,11 % ) | 3 Mio $ | 31.08.2026 |
| Unternehmen | Position | Beginn |
|---|---|---|
| BEAM THERAPEUTICS INC. | General Counsel | 01.04.2019 |
Museum of Science
Museum of Science Other Consumer ServicesConsumer Services Operates as a museum | Direktor/Vorstandsmitglied | - |
| Unternehmen | Position | Ende |
|---|---|---|
Forma Therapeutics, Inc.
Forma Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines for cancer and other genetically driven diseases | General Counsel | 01.04.2019 |
| RELAY THERAPEUTICS, INC. | General Counsel | 01.10.2017 |
| BLUEPRINT MEDICINES CORPORATION | General Counsel | 02.09.2016 |
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Corporate Officer/Principal | - |
Fish & Richardson PC
Fish & Richardson PC Miscellaneous Commercial ServicesCommercial Services Provides intellectual property, litigation, transactional, and regulatory services | Corporate Officer/Principal | - |
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
| Private Unternehmen | 12 |
|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes pharmaceuticals, vaccines & biotechnology products | Health Technology |
Forma Therapeutics, Inc.
Forma Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops medicines for cancer and other genetically driven diseases | Health Technology |
Infinity Pharmaceuticals, Inc.
Infinity Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops medicines for the treatment of cancer | Health Technology |
Massachusetts Institute of Technology
Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hydra Biosciences, Inc.
Hydra Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops molecular regeneration medicines to treat pain, inflammation, anxiety and other diseases | Health Technology |
Fish & Richardson PC
Fish & Richardson PC Miscellaneous Commercial ServicesCommercial Services Provides intellectual property, litigation, transactional, and regulatory services | Commercial Services |
Museum of Science
Museum of Science Other Consumer ServicesConsumer Services Operates as a museum | Consumer Services |
Columbia Law School
Columbia Law School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Blueprint Medicines Corp.
Blueprint Medicines Corp. BiotechnologyHealth Technology Develops cancer therapies that harness the growing understanding of the molecular blueprint of cancer | Health Technology |
Relay Therapeutics, Inc.
Relay Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical-stage precision medicine company, which focus on enhancing small molecule therapeutic discovery in targeted oncology | Health Technology |
Beam Therapeutics, Inc.
Beam Therapeutics, Inc. BiotechnologyHealth Technology Operate as a biotechnology company that develops precision genetic medicines, gene editing and delivery technologies | Health Technology |
Bitte wählen Sie Ihre Ausgabe
Alle länderspezifischen Finanzinformationen